Divergent T-cell receptor recognition modes of a HLA-I restricted extended tumour-associated peptide.
Chan, K.F., Gully, B.S., Gras, S., Beringer, D.X., Kjer-Nielsen, L., Cebon, J., McCluskey, J., Chen, W., Rossjohn, J.(2018) Nat Commun 9: 1026-1026
- PubMed: 29531227 
- DOI: 10.1038/s41467-018-03321-w
- Primary Citation of Related Structures:  
6AT5, 6AT6, 6AVF, 6AVG - PubMed Abstract: 
Human leukocyte antigen (HLA)-I molecules generally bind short peptides (8-10 amino acids), although extended HLA-I restricted peptides (>10 amino acids) can be presented to T cells. However, the function of such extended HLA-I epitopes in tumour immunity, and how they would be recognised by T-cell receptors (TCR) remains unclear ...